China National Center For Cardiovascular Diseases

This study tests whether Xuesaitong soft capsules can lower inflammation and improve other risk factors in 240 adults with stable coronary heart disease. Participants take the capsules or a placebo for 12 weeks, and researchers measure changes in blood markers like hsCRP. The goa…

This study tests a new surgical technique that avoids touching the aorta during heart bypass surgery to reduce the risk of brain complications like stroke or silent brain injury. About 380 adults with blocked heart arteries will be randomly assigned to receive either the new tech…

This study aims to find the best blood-thinning medication combination for patients who have undergone a complex heart bypass surgery called coronary endarterectomy combined with CABG. Researchers will compare two drug regimens to see which one better keeps the new bypass grafts …

This study tests an artificial intelligence (AI) program that looks at facial photos to screen for coronary artery disease (CAD) in people at high risk (those with diabetes, high blood pressure, or over 65). About 1,392 participants will have their face scanned by the AI, then al…